Patients treated with transcatheter aortic valve replacement (TAVR) for bicuspid aortic stenosis are less likely to be discharged with a disability if treated at a high-volume structural heart center, according to new data presented Thursday at the Society of Cardiovascular Angiography and Interventions 2020 virtual conference.